The Use of Mucograft® to Treat Gingival Recession
Launched by DAMASCUS UNIVERSITY · Dec 5, 2016
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
Many surgical techniques have used to treat gingival recession such aas repositioned flaps, autologous soft tissue grafts (connective tissue graft or free gingival grafts) or allografts like acellular dermal which can be used as substitutes for palatal donor tissue. Mucograft® (3D collagen matrix) is also an allograft from porcine origin and is designed for soft tissue regeneration and considered the ideal solution to autogenous soft tissue grafts and it provides an ideal matrix for blood vessel and soft tissue ingrowth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of Type I or II (Miller Classification) of gingival recession
- Exclusion Criteria:
- • Smoking
- • Pregnancy or lactating
- • Presence of any systematic diseases can affect the periodontal surgery.
- • Subjects with significant moderate to severe periodontal disease.
- • Patients under orthodontic treatment
- • Presence of restorative materials (e.g. crown)
- • Effectiveness of frenum
- • Subjects have failed to maintain good plaque control.
- • Subjects having previous surgical treatment for covering the recession in the chosen area.
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
Patients applied
Trial Officials
Haydar Barakat, DDS MSc
Principal Investigator
PhD Student in Periodontics, University of Damascus Dental School, Damascus, Syria
Suleiman Dayoub, DDS MSc PhD
Study Director
Associate Professor of Periodontics, Department of Peridontics, Univ. of Damascus Dental School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials